BSE filing, NSE: KRSNAA. Summary written from the filing by ALFA Finder's alert engine.
Krsnaa Diagnostics Ltd: key numbers
- Share price
- ₹496.45
- Market cap
- ₹1,610 Cr
- Revenue (annual)
- ₹772.8 Cr
- Net profit (annual)
- ₹101.4 Cr
- P/E (TTM)
- 16.5×Sector 52.0×
- Promoter holding
- 27.11%+0.00% QoQ
- FII holding
- 3.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krsnaa Diagnostics Ltd
All →Krsnaa Diagnostics Board Meeting Date
Krsnaa Diagnostics intimated that its board will meet on November 2, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. No financial figures are disclosed in this notice.
Krsnaa Diagnostics Partnership
Krsnaa Diagnostics has formed a strategic AI collaboration with AZmed to integrate AI radiology solutions for enhanced operational efficiency and scalable diagnostic reporting.
- From
- AZmed
Krsnaa Diagnostics Other Announcement
Krsnaa Diagnostics Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Krsnaa Diagnostics Convertible Warrants
Krsnaa Diagnostics has allotted 16,21,000 convertible warrants to 2 investors at a price of Rs. 566 per warrant.
- Value
- ₹91.75 Cr
Krsnaa Diagnostics Convertible Warrants
Krsnaa Diagnostics allotted 16.21 lakh convertible warrants to promoter entities at ₹566 per warrant. The company collected ₹22.94 Crore as 25% upfront subscription money.
- Value
- ₹22.94 Cr
Krsnaa Diagnostics Capital Structure Change
Krsnaa Diagnostics received in-principle approval from BSE and NSE to issue 16.21 lakh convertible warrants at Rs. 566 per share to the promoter group.
- Value
- ₹91.75 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.